Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Haven, Connecticut 06511


Purpose:

This study is a six-week, randomized, placebo-controlled, fixed dose trial comparing cannabidiol Vs. placebo added to a stable dose of antipsychotic medications in patients diagnosed with schizophrenia.


Criteria:

Inclusion Criteria: - Schizophrenia or Schizoaffective disorder (DSM-IV SCID-confirmed), Exclusion Criteria: - Women who are pregnant, nursing or unwilling to use appropriate birth control measures during study participation.


NCT ID:

NCT00588731


Primary Contact:

Principal Investigator
Mohini Ranganathan, M.D.
Yale University


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06511
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.